Skip to main content
OpenTrials

Clinical trial condition

Peripheral Nervous System Diseases

Explore clinical trials studying Peripheral Nervous System Diseases. Study availability and eligibility vary by location and protocol.

3,127 public trials 570 recruiting studies
Refine in advanced search Browse all conditions

Peripheral Nervous System Diseases trial results

Recruiting

ConTTRibute: A Global Observational Study of Patients With Transthyretin (TTR)-Mediated Amyloidosis (ATTR Amyloidosis)

NCT04561518

Conditions
ATTR Amyloidosis, Amyloid Neuropathies, Amyloid Neuropathies, Familial, +16 more
Locations
  • Clinical Trial Site La Jolla, California, United States
  • Clinical Trial Site Los Angeles, California, United States
  • Clinical Trial Site Jacksonville, Florida, United States
  • Clinical Trial Site Iowa City, Iowa, United States
View all 40 locations
View Trial Details
Recruiting

An Open Label Clinical Study to Evaluate Tanruprubart (Also Commonly Known as ANX005) in Participants With Guillain-Barré Syndrome (FORWARD Study)

NCT07020819

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +12 more
Locations
  • St. Joseph's Hospital & Medical Center - Barrow Neurological Institute Phoenix, Arizona, United States
  • HonorHealth Bob Bové Neuroscience Institute Scottsdale, Arizona, United States
  • Profound Research LLC Carlsbad, California, United States
  • Children's Hospital of Orange County Orange, California, United States
View all 13 locations
View Trial Details
Recruiting

A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)

NCT07175038

Conditions
Cardiovascular Diseases, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +18 more
Locations
  • Arizona Pulmonary Specialists Phoenix, Arizona, United States
  • University of California Davis Health Rancho Cordova, California, United States
  • University of Colorado Aurora, Colorado, United States
  • George Washington University Medical Washington D.C., District of Columbia, United States
View all 19 locations
View Trial Details
Recruiting

Evaluate the Safety and Efficacy of EN001 in Patients With Charcot-Marie-Tooth Disease Type 1A(CMT1A) (Phase 1b: Open-label, Dose-escalation, Single-center; Phase 2a: Randomized, Double-blind, Placebo-controlled, Multicenter)

NCT06328712

Conditions
Charcot-Marie-Tooth Disease, Charcot-Marie-Tooth Disease Type 1A, Congenital Abnormalities, +10 more
Locations
  • Dongguk University Gyeongju Hospital Gyeongju, South Korea
  • Kyung Hee University Hospital at Gangdong Seoul, South Korea
  • Samsung Medical Center Seoul, South Korea
View Trial Details

Related conditions